Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles

Clinical and Experimental Allergy

Volumn 26, Issue 11, 1996, Pages 1286-1297

  Tengvall Linder, M ^a   Johansson, C ^a   Zargari, A ^a   Bengtsson, A ^a   Van Der Ploeg, I ^a   Jones, I ^b   Harfast B ^a   Scheynius, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Diagnostics   (Sweden)

Author keywords

Cytokines; IgE; Skin biopsy specimens; T cell clones

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; MESSENGER RNA;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; MALE; PITYROSPORUM ORBICULARE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; ANTIGENS, FUNGAL; CELL DIVISION; CYTOKINES; DERMATITIS, ATOPIC; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; MALASSEZIA; MALE; MIDDLE AGED; SKIN; T-LYMPHOCYTES;

EID: 0029860543     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00526.x     Document Type: Article

References (36)

1. Öhman S, Johansson SGO. Immunoglobulins in atopic dermatitis. Acta Derm Venereol (Stockh) 1974; 54:193-202.
2. van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS, Maggi E, Romagnani S, Westland JKT, Mudde GC. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992; 90:184-93.
3. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102:128-37.
4. Bos JD, Kapsenberg ML, Sillevis Smitt JH. Pathogenesis of atopic eczema. Lancet 1994; 343:1338-41.
5. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992; 89:801-10.
6. Roberts SOB. Pityrosporum orbiculare: incidence and distribution on clinically normal skin. Br J Dermatol 1969; 81:264-9.
7. Faergemann J. Tinea versicolor and Pityrosporum orbiculare: mycological investigations, experimental infections and epidemiological surveys. Acta Derm Venereol (Stockh) 1979; 86(Suppl):1-23.
8. Kieffer M, Bergbrant I-M, Faergemann J, Jemec GBE, Ottevanger V, Stahl Skov P, Svejgaard E. Immune reactions to Pityrosporum orale in adult patients with atopic and seborrhoeic dermatitis. J Am Acad Dermatol 1990; 22: 739-42.
9. Nordvall SL, Johansson S. IgE antibodies to Pityrosporum orbiculare in children with atopic diseases. Acta Paediatr Scand 1990; 79:343-8.
10. Jensen-Jarolim E, Poulsen LK, With H, Kieffer M, Ottevanger V, Stahl Skov P. Atopic dermatitis of the face, scalp, and neck: type 1 reaction to the yeast Pityrosporum ovale?. J Allergy Clin Immunol 1992; 89:44-51.
11. Broberg A, Faergemann J, Johansson S, Johansson SGO, Strannegård I-L, Svejgaard E. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol (Stockh) 1992; 72:187-92.
12. Zargari A, Härfast B, Johansson S, Johansson SGO, Scheynius A. Identification of allergen components of the opportunistic yeast Pityrosporum orbiculare by monoclonal antibodies. Allergy 1994; 49:50-6.
13. Bäck O, Scheynius A, Johansson SGO. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995; 287: 448-51.
14. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92(Suppl):44-7.
15. Sharrock CEM, Kaminski E, Man S. Limiting dilution analysis of human T-cells: a useful clinical tool. Immunol Today 1990; 11:281-6.
16. Ebner C, Schenk S, Najafian N et al. Nonallergic individuals recognize the same T cell epitopes of bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 1995; 154:1932-40.
17. Pisa EK, Pisa P, Hansson M, Wigzell H. OKT3-induced cytokine mRNA expression in human peripheral blood mononuclear cells measured with polmerase chain reaction. Scand J Immunol 1992; 36:745-9.
18. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277-9.
19. Minty A, Chalon P, Derocq J-M et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-50.
20. Waersted A, Hjorth N. Pityrosporum orbiculare: a pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derm Venereol (Stockh) 1985; 114 (Suppl.):146-8.
21. Rokugo M, Tagami H, Usuba Y, Tomita Y. Contact sensitivity to Pityrosporum ovale in patients with atopic dermatitis. Arch Dermatol 1990; 126:627-32.
22. Kröger S, Neuber K, Gruseck E, Ring J, Abeck D. Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema. Acta Derm Venereol (Stockh) 1995; 75:357-60.
23. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. N Engl J Med 1985; 313:282-5.
24. Wahlgren C-F, Tengvall Linder M, Scheynius A. Effects of cyclosporin A in atopic dermatitis: expression in the skin of IgE, low-affinity Fc-IgE receptors, ICAM-1 and eosinophilic granulocytes. Eur J Dermatol 1992; 2:112-18.
25. Bruynzeel-Koomen C, van Wichen DF, Toonstra J, Berrens L, Bruynzeel PLB. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res 1986; 278:199-205.
26. Mudde GC, van Reijsen FC, Boland GJ, de Gast GC, Bruijnzeel PLB, Bruijnzeel-Koomen CAFM. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunol 1990; 69:335-41.
27. Maurer D, Stingl G. Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood. J Invest Dermatol 1995; 104:707-10.
28. Mudde GC, Bheekha R, Bruijnzeel-Koomen CAFM. IgE-mediated antigen presentation. Allergy 1995; 50:193-9.
29. Furue M, Ohtsuki M, Ogaka, F, Ishibashi Y. Responsiveness to interleukin 4 and interleukin 2 of peripheral blood mononuclear cells in atopic dermatitis. J Invest Dermatol 1991; 96:468-72.
30. Reinhold U, Kukel S, Goeden B, Neuman U, Wehrmann W, Kreysel H-W. Interleukin-4 promotes the expansion of skin-infiltrating lymphocytes from atopic dermatitis in vitro. J Invest Dermatol 1991; 96:370-5.
31. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97:389-94.
32. Kägi MK, Wuthrich B, Montano E, Barandun J, Blaser K, Walker C. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 1994; 103:332-40.
33. McKenzie ANJ, Culpepper JA, de Waal Malefyt R et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90:3735-9.
34. Punnonen J, Aversa G, Cocks BG et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90:3730-4.
35. de Vries JE, Zurawski G. Immunoregulatory properties of IL-13: its potential role in atopic disease. Int Arch Allergy Immunol 1995; 106:175-9.
36. van der Ploeg I, Scheynius A, Tengvall Linder M, Hägermark Ö, Wahlgren C-F. Elevated gene expression for interleukin-13 in the skin of atopic dermatitis patients. Allergy 1995; 50(Suppl 26):364-365 (abstr).